July 26, 2018 / 10:39 AM / 4 months ago

Botox-maker Allergan posts smaller quarterly loss

July 26 (Reuters) - Allergan Plc posted a smaller second-quarter loss on Thursday due to demand for the company’s Botox anti-wrinkle treatment.

The company reported net loss attributable to ordinary shareholder’s of $472.5 million, or $1.39 per share, in the second quarter ended June 30, compared with a loss of $795.5 million, or $2.37 per share, a year ago.

Revenue rose 2.9 percent to $4.12 billion. (Reporting by Manas Mishra in Bengaluru Editing by Saumyadeb Chakrabarty)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below